Home
>
National Drug Code (NDC)
>
Enablex
Enablex - 0078-0419-34 - (darifenacin)
Drug Information of Enablex
| Product NDC: | 0078-0419 |
| Proprietary Name: | Enablex |
| Non Proprietary Name: | darifenacin |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; darifenacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Enablex
| Product NDC: | 0078-0419 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021513 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041222 |
Package Information of Enablex
| Package NDC: | 0078-0419-34 |
| Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0078-0419-34) |
NDC Information of Enablex
| NDC Code | 0078-0419-34 |
| Proprietary Name | Enablex |
| Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0078-0419-34) |
| Product NDC | 0078-0419 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | darifenacin |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20041222 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DARIFENACIN |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
